US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist
  • 5.670
  • -0.040-0.70%
Trading Jan 22 11:31 ET
109.55MMarket Cap-4.89P/E (TTM)

About Nuvectis Pharma Company

Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.

Company Profile

SymbolNVCT
Company NameNuvectis Pharma
Listing DateFeb 4, 2022
Issue Price5.00
Founded2020
CEOMr. Ron Bentsur
MarketNASDAQ
Employees13
Fiscal Year Ends12-31
Address1 Bridge Plaza,Suite 275,2nd floor
CityFort Lee
ProvinceNew Jersey
CountryUnited States of America
Zip Code07024
Phone1-201-614-3151
Websitehttp://nuvectis.com

Company Executives

  • Name
  • Position
  • Salary
  • Ron Bentsur
  • Chairman of the Board, Chief Executive Officer and President
  • 2.69M
  • Enrique Poradosu
  • Executive Vice President, Chief Scientific and Business Officer
  • 1.56M
  • Shay Shemesh
  • Executive Vice President, Chief Development and Operations Officer
  • 1.56M
  • Michael J. Carson
  • Vice President of Finance, Principal Financial and Accounting Officer
  • --
  • James F. Oliviero, III
  • Independent Director
  • 385.80K
  • Matthew L. Kaplan
  • Independent Director
  • 375.80K
  • Kenneth Hoberman
  • Independent Director
  • 385.80K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Shantou Institute of Ultrasonic Instrument
301602
+379.10%
Hubei Sinophorus Electronic Materials
688545
+134.50%
Pansoft
300996
+20.01%
4
Jiayu Holding
300117
+20.00%
5
Wuxi Taclink Optoelectronics Technology
688205
+15.75%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
China Concept Stocks
Tracking the US-listed Chinese companies.
Discussing
U.S.-China talks spark interest, no more inflation?
🎙️Discussion: 1. How will Trump's China policies affect Chinese assets? 2. Which sectors might benefit as U.S. inflation risks decline? Show More
China Will Adopt a "Moderately Accommodative" Monetary Policy in the Next Year, The First Shift to Easing Since 2011